首页|横纹肌肉瘤组织Ki-67表达与临床病理特征及预后的关系

横纹肌肉瘤组织Ki-67表达与临床病理特征及预后的关系

扫码查看
目的 观察横纹肌肉瘤患者肿瘤组织Ki-67表达变化,探讨其与临床病理特征及预后的关系.方法 回顾性分析2017年1月-2022年12月郑州大学第一附属医院行手术治疗的118例横纹肌肉瘤患者(年龄≤18岁)的临床资料.随访至2023年4月,记录患者生存情况.绘制ROC曲线,评估Ki-67指数预测横纹肌肉瘤患者术后死亡的效能.以Ki-67指数预测横纹肌肉瘤患者术后死亡的最佳截断值为界,将118例患者分为高表达组和低表达组,比较2组性别、年龄、肿瘤最大直径、肿瘤位置、组织病理类型、TNM分期、美国横纹肌肉瘤研究组(IRS)分期等临床资料;绘制Kaplan-Meier生存曲线,比较2组总生存率;采用单因素及多因素Cox回归分析横纹肌肉瘤患者术后死亡的影响因素.结果 (1)随访至2023年4月30日,中位随访26.5个月,118例中生存77例,死亡41例.Ki-67指数以65%为最佳截断值,预测横纹肌肉瘤患者死亡的AUC为0.725(95%CI:0.633~0.817,P<0.001),灵敏度为73.2%,特异度为64.9%.(2)118例中61例Ki-67指数≤65%者为低表达组,57例Ki-67指数>65%者为高表达组.高表达组总生存率(47.4%)低于低表达组(82.0%)(x2=19.552,P<0.001).(3)高表达组IRS分期Ⅳ期(33.3%)、中高危(57.9%)比率均高于低表达组(6.6%、31.1%)(P<0.05),男性、年龄>10岁、肿瘤最大直径>5 cm、肿瘤位置、TNM分期Ⅲ~Ⅳ期、术后放疗比率及组织病理类型与低表达组比较差异均无统计学意义(P>0.05).(3)年龄>10岁(HR=2.582,95%CI:1.336~4.990,P=0.005)、Ki-67高表达(HR=3.328,95%CI:1.517~7.301,P=0.003)是横纹肌肉瘤患者术后死亡的危险因素,术后放疗(HR=0.267,95%CI:0.079~0.903,P=0.034)、危险度为低危(HR=0.398,95%CI:0.166~0.954,P=0.039)是横纹肌肉瘤患者术后死亡的保护因素.结论 Ki-67高表达的横纹肌肉瘤患者IRS分期晚,预后差;年龄>10岁、危险度为中高危、Ki-67指数>65%是影响横纹肌肉瘤患者术后死亡的危险因素,术后放疗可改善预后.
Relationships of Ki-67 expression with clinicopathological features and prognosis of rhabdomyosarcoma patients
Objective To observe the expression of Ki-67 in rhabdomyosarcoma patients,and to explore its relationship with clinicopathological features and prognosis.Methods Totally 118 patients(≤18 years old)with rhabdomyosarcoma undergoing surgical treatment in the First Affiliated Hospital of Zhengzhou University from January,2017 to December,2022,and their clinical data were retrospectively analyzed.The patients were followed up till April,2023,and the survival of the patients was recorded.ROC curve was plotted to evaluate the efficiency of Ki-67 on predicting the postoperative death.Taking the optimal cut-off value of Ki-67 for predicting the postoperative death as the boundary value,118 patients were divided into high-expression group and low-expression group.The gender,age,maximal tumor diameter,tumor location,histopathological type,TNM stage and Intergroup Rhabdomyosarcoma Study(IRS)stage were compared between two groups.Kaplan-Meier survival curve was plotted to compare the total survival rate between two groups.Univariate and multivariate Cox regression analyses were used to analyze the influencing factors of postoperative death in rhabdomyosarcoma patients.Results(1)The patients were followed up till April 30,2023,with a median follow-up of 26.5 months.Of 118 patients,77 survived and 41 died.When the optimal cut-off value of Ki-67 was 65%,the AUC for predicting death of rhabdomyosarcoma patients was 0.725(95%CI:0.633-0.817,P<0.001),with a sensitivity of 73.2%and specificity of 64.9%.(2)In 118 patients,Ki-67 was ≤65%in 61 patients(low-expression group)and was>65%in 57 patients(high-expression group).The total survival rate was lower in high-expression group(47.4%)than that in low-expression group(82.0%)(x2=19.552,P<0.001).(3)The rates of IRS stage Ⅳand medium-high risk were higher in high-expression group(33.3%,57.9%)than those in low-expression group(6.6%,31.1%)(P<0.05).There were no significant differences in the proportions of males,age>10 years old,maximal tumor diameter>5 cm,tumor location,TNM stage Ⅲ-Ⅳ and postoperative radiotherapy as well as the histopathological type between two groups(P>0.05).(4)Age>10 years old(HR=2.582,95%CI:1.336-4.990,P=0.005)and Ki-67 high expression(HR=3.328,95%CI:1.517-7.301,P=0.003)were the risk factors of death of rhabdomyosarcoma patients,and postoperative radiotherapy(HR=0.267,95%CI:0.079-0.903,P=0.034)and low risk(HR=0.398,95%CI:0.166-0.954,P=0.039)were the protective factors of death.Conclusions The children with high expression of Ki-67 have advanced IRS stage and poor prognosis.Age>10 years old,medium-high risk,and Ki-67>65%are the risk factors of postoperative death of rhabdomyosarcoma patients,and postoperative radiotherapy can improve the prognosis.

rhabdomyosarcomaKi-67prognosis

裴家鑫、吕新全、周雅淑、苏彦威、路太英

展开 >

郑州大学第一附属医院肿瘤科,河南郑州 450052

郑州大学第一附属医院病理科,河南郑州 450052

横纹肌肉瘤 Ki-67 预后

河南省医学科技攻关计划省部共建重点项目

SBGJ202002068

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(7)